Abstract
Throwing tumors a left-hook punch: The oncoprotein MDM2 negatively regulates the activity and stability of the tumor suppressor protein p53, and is an important molecular target for anticancer therapy. Mirror-image phage display identified a high-affinity D-peptide ligand of MDM2 (see structure) that could be developed into a potent and protease-resistant p53 activator with potential antitumor activity. (Figure Presented)
| Original language | English |
|---|---|
| Pages (from-to) | 3649-3652 |
| Number of pages | 4 |
| Journal | Angewandte Chemie - International Edition |
| Volume | 49 |
| Issue number | 21 |
| DOIs | |
| State | Published - 10 May 2010 |
| Externally published | Yes |
Keywords
- Antitumor agents
- MDM2
- P53
- Protein structures
- Protein-protein interactions